Choice and Interpretation of Statistical Tests Used When Competing Risks Are PresentDIGNAM, James J; KOCHERGINSKY, Maria N.Journal of clinical oncology. 2008, Vol 26, Num 24, pp 4027-4034, issn 0732-183X, 8 p.Article

The Use and Interpretation of Competing Risks Regression ModelsDIGNAM, James J; QIANG ZHANG; KOCHERGINSKY, Masha et al.Clinical cancer research (Print). 2012, Vol 18, Num 8, pp 2301-2308, issn 1078-0432, 8 p.Article

Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancerDIGNAM, James J; POLITE, Blase N; YOTHERS, Greg et al.Journal of the National Cancer Institute. 2006, Vol 98, Num 22, pp 1647-1654, issn 0027-8874, 8 p.Article

Hormone Replacement Therapy and Breast Cancer: Heterogeneous Risks by Race, Weight, and Breast DensityNINGQI HOU; SUSAN HONG; WENLI WANG et al.Journal of the National Cancer Institute. 2013, Vol 105, Num 18, pp 1365-1372, issn 0027-8874, 8 p.Article

Prognosis after rectal cancer in blacks and whites participating in adjuvant therapy randomized trialsDIGNAM, James J; YUNRONG YE; COLANGELO, Linda et al.Journal of clinical oncology. 2003, Vol 21, Num 3, pp 413-420, issn 0732-183X, 8 p.Article

Multiple imputation methods for inference on cumulative incidence with missing cause of failureLEE, Minjung; CRONIN, Kathleen A; GAIL, Mitchell H et al.Biometrical journal. 2011, Vol 53, Num 6, pp 974-993, issn 0323-3847, 20 p.Article

Population-based survival-cure analysis of ER-negative breast cancerLAN HUANG; JOHNSON, Karen A; MARIOTTO, Angela B et al.Breast cancer research and treatment. 2010, Vol 123, Num 1, pp 257-264, issn 0167-6806, 8 p.Article

Estimating Breast Cancer-Specific and Other-Cause Mortality in Clinical Trial and Population-Based Cancer Registry CohortsDIGNAM, James J; LAN HUANG; RIES, Lynn et al.Cancer. 2009, Vol 115, Num 22, pp 5272-5283, issn 0008-543X, 12 p.Article

Hazard of recurrence and adjuvant treatment effects over time in lymph node-negative breast cancerDIGNAM, James J; DUKIC, Vanja; ANDERSON, Stewart J et al.Breast cancer research and treatment. 2009, Vol 116, Num 3, pp 595-602, issn 0167-6806, 8 p.Article

Prognosis After Ipsilateral Breast Tumor Recurrence and Locoregional Recurrences in Patients Treated by Breast-Conserving Therapy in Five National Surgical Adjuvant Breast and Bowel Project Protocols of Node-Negative Breast CancerANDERSON, Stewart J; WAPNIR, Irene; DIGNAM, James J et al.Journal of clinical oncology. 2009, Vol 27, Num 15, pp 2466-2473, issn 0732-183X, 8 p.Article

Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancerDIGNAM, James J; WIEAND, Kelly; JOHNSON, Karen A et al.Breast cancer research and treatment. 2006, Vol 97, Num 3, pp 245-254, issn 0167-6806, 10 p.Article

Is patient travel distance associated with survival on phase II clinical trials in oncology?LAMONT, Elizabeth B; HAYREH, Davinder; PICKETT, Kate E et al.Journal of the National Cancer Institute. 2003, Vol 95, Num 18, pp 1370-1375, issn 0027-8874, 6 p.Article

Glioma-Associated Oncogene Family Zinc Finger 1 Expression and Metastasis in Patients With Head and Neck Squamous Cell Carcinoma Treated With Radiation Therapy (RTOG 9003)CHUNG, Christine H; DIGNAM, James J; LE, Quynh-Thu et al.Journal of clinical oncology. 2011, Vol 29, Num 10, pp 1326-1334, issn 0732-183X, 9 p.Article

Conditional Survival and the Choice of Conditioning Set for Patients With Colon Cancer: An Analysis of NSABP Trials C-03 Through C-07ZAMBONI, Beth A; YOTHERS, Greg; CHOI, Mehee et al.Journal of clinical oncology. 2010, Vol 28, Num 15, pp 2544-2548, issn 0732-183X, 5 p.Article

Predictors of Competing Mortality in Advanced Head and Neck CancerMELL, Loren K; DIGNAM, James J; VOKES, Everett E et al.Journal of clinical oncology. 2010, Vol 28, Num 1, pp 15-20, issn 0732-183X, 6 p.Article

Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancerDIGNAM, James J; WIEAND, Kelly; JOHNSON, Karen A et al.Journal of the National Cancer Institute. 2003, Vol 95, Num 19, pp 1467-1476, issn 0027-8874, 10 p.Article

Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence After lumpectomy in women with invasive breast cancers of one centimeter or lessFISHER, Bernard; BRYANT, John; DIGNAM, James J et al.Journal of clinical oncology. 2002, Vol 20, Num 20, pp 4141-4149, issn 0732-183X, 9 p.Article

Predictors of Locoregional Recurrence After Neoadjuvant Chemotherapy: Results From Combined Analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27MAMOUNAS, Eleftherios P; ANDERSON, Stewart J; DIGNAM, James J et al.Journal of clinical oncology. 2012, Vol 30, Num 32, pp 3960-3966, issn 0732-183X, 7 p.Article

Epidermal Growth Factor Receptor Inhibitor Gefitinib Added to Chemoradiotherapy in Locally Advanced Head and Neck CancerCOHEN, Ezra E. W; HARAF, Daniel J; WITT, Mary Ellyn et al.Journal of clinical oncology. 2010, Vol 28, Num 20, pp 3336-3343, issn 0732-183X, 8 p.Article

Colorectal cancer model of health disparities : Understanding mortality differences in minority populationsPOLITE, Blase N; DIGNAM, James J; OLOPADE, Olufunmilayo I et al.Journal of clinical oncology. 2006, Vol 24, Num 14, pp 2179-2187, issn 0732-183X, 9 p.Article

MYC is amplified in BRCA1-associated breast cancersGRUSHKO, Tatyana A; DIGNAM, James J; SVEEN, Lise et al.Clinical cancer research. 2004, Vol 10, Num 2, pp 499-507, issn 1078-0432, 9 p.Article

Mammographic density and breast cancer after ductal carcinoma in situHABEL, Laurel A; DIGNAM, James J; LAND, Stephanie R et al.Journal of the National Cancer Institute. 2004, Vol 96, Num 19, pp 1467-1472, issn 0027-8874, 6 p.Article

A Randomized Trial of Bevacizumab for Newly Diagnosed GlioblastomaGILBERT, Mark R; DIGNAM, James J; JERAJ, Robert et al.The New England journal of medicine. 2014, Vol 370, Num 8, pp 699-708, issn 0028-4793, 10 p.Article

NCI―RTOG Translational Program Strategic Guidelines for the Early-Stage Development of RadiosensitizersLAWRENCE, Yaacov Richard; VIKRAM, Bhadrasain; COLEMAN, C. Norman et al.Journal of the National Cancer Institute. 2013, Vol 105, Num 1, pp 11-24, issn 0027-8874, 14 p.Article

Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice GuidelineGRIGGS, Jennifer J; MANGU, Pamela B; SHAYNE, Michelle et al.Journal of clinical oncology. 2012, Vol 30, Num 13, pp 1553-1561, issn 0732-183X, 9 p.Article